Notch Inhibitor in Advanced Cancer

NCT01158404 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

35

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Cancer

Interventions

DRUG: LY900009 - Dose Escalation Phase (Part A)
DRUG: LY900009 - Dose Confirmation Phase (Part B)

Sponsor

Eli Lilly and Company